CSIMarket
 

Xtant Medical Holdings Inc   (XTNT)
Other Ticker:  
 

Xtant Medical Holdings Inc 's Working Capital Per Sales

XTNT's Working Capital and Revenue growth



XTNT Working Capital Per Revenue (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Working Capital Change 25 % -27.19 % -39.72 % 1.05 % -5.37 %
Y / Y Revenue Change 68.26 % 27.37 % 38.46 % 9.32 % 4.97 %
Working Capital Per Revenue 0.38 0.41 0.47 0.56 0.58
Total Ranking # 2156 # 2299 # 2399 # 2846 # 2463
Seq. Working Capital Change 86.81 % 16.94 % -43.37 % 1.04 % 8.82 %
Seq. Revenue Change 25.05 % 8.45 % 17.5 % 5.59 % -5.33 %





Comment on XTNT's Working Capital Per Revenue in the third quarter 2023
Xtant Medical Holdings Inc 's Working Capital Per Revenue in the Q3 2023 sequentially fell to 0.38 but remained above Xtant Medical Holdings Inc 's average.

Within Healthcare sector 80 other companies have achieved lower Working Capital Per Revenue during the Q3 2023. While Xtant Medical Holdings Inc Working Capital Per Revenue overall ranking has impoved so far in the Q3 2023 to 2156, from total ranking in the second quarter 2023 at 2299.
Working Capital Per Revenue Ranking
Within: No.
Industry # 11
Sector # 81
S&P 500 # 2156


Working Capital Per Revenue Statistics
High Average Low
0.61
0.34
0.02
(Mar 31 2022)   (Dec 31 2017)



Financial Statements
Xtant Medical Holdings Inc 's Working Capital $ 42 Millions Visit XTNT's Balance sheet
Xtant Medical Holdings Inc 's Revenues $ 24 Millions Visit XTNT's Income Statement
Where are XTNT's Sales coming from? Visit XTNT's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Sep 30 2023, within Healthcare Sector Working Capital Per Revenue
Omniab Inc   1.05 
Alpha Teknova Inc   1.04 
Y mabs Therapeutics inc   1.04 
Innoviva Inc   1.03 
Spero Therapeutics Inc   1.02 
Arcturus Therapeutics Holdings Inc   1.02 
Treace Medical Concepts Inc   1.02 
Cue Health Inc   1.02 
Intercept Pharmaceuticals inc   1.01 
Coherus Biosciences inc   1.01 
Ispecimen inc   1.00 
Icad Inc  1.00 
Caredx Inc   0.98 
Venus Concept Inc   0.98 
Sunshine Biopharma Inc   0.98 
Adma Biologics Inc   0.98 
Ardelyx Inc   0.98 
Iradimed Corporation  0.98 
Exagen Inc   0.97 
Bio rad Laboratories Inc   0.96 
23andme Holding Co  0.95 
Biomarin Pharmaceutical Inc  0.93 
Seres Therapeutics Inc   0.92 
Amgen Inc   0.92 
Organigram Holdings Inc   0.92 
Ironwood Pharmaceuticals inc   0.92 
Neuronetics inc   0.91 
Repligen Corp  0.91 
Mei Pharma Inc   0.89 
Natera inc   0.89 
Date modified: 2023-12-03T16:27:42+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com